Philip Chapper and Company, a leading pharmaceutical and medical equipment supplier, is set to showcase its new non-invasive blood sugar monitoring device for people with diabetes at the upcoming Arab Health 2014 in Dubai.
Philip

Sanofi's candidate drug Lyxumia or lixisenatide, added to basal insulin, significantly reduced blood sugar levels in type 2 diabetes patients and also led to a loss in weight, data published on Tuesday showed.
Lixisenatide belongs to the G

An intensive programme that taught low-income, poorly educated diabetics to better manage their disease resulted in significantly improved long-term blood sugar control, according to university researchers.
The findings from Baltimore-base

People who eat brown rice or other whole grains seem to have a lower risk of developing diabetes than those who eat white rice, according to a US study.
A team of researchers from the Harvard School of Public Health and Brigham and Women

The Advance trial, the world’s largest study of diabetes treatments, showed lately that intensive blood sugar control using modified release gliclazide and other drugs as required protects patients against serious complications of the disease.